Skip NavigationSkip to Content

Lck Associates With and Is Activated By Kit in a Small Cell Lung Cancer Cell Line - Inhibition of Scf-Mediated Growth By the Src Family Kinase Inhibitor Pp1

  1. Author:
    Krystal, G. W.
    Deberry, C. S.
    Linnekin, D.
    Litz, J.
  2. Author Address

    Krystal GW RICHMOND VET AFFAIRS MED CTR 111K 1201 BROAD ROCK BLVD RICHMOND, VA 23249 USA VIRGINIA COMMONWEALTH UNIV MED COLL VIRGINIA MCGUIRE VET AFFAIRS MED CTR DEPT MED RICHMOND, VA 23249 USA NCI LAB LEUKOCYTE BIOL DIV BASIC SCI FREDERICK CANC RES & DEV CTR FREDERICK, MD 21702 USA
    1. Year: 1998
  1. Journal: Cancer Research
    1. 58
    2. 20
    3. Pages: 4660-4666
  2. Type of Article: Article
  1. Abstract:

    At least 70% of small cell lung cancers (SCLCs) express the Kit receptor tyrosine kinase and its ligand, stem cell factor (SCF), In an effort to define the signal transduction pathways activated by Kit in SCLC,,ce focused on Src family kinases and, in particular, Lck, a Src-related tyrosine kinase that is expressed in hemopoietic cells and certain tumors, including SCLC. SCF treatment of the H526 cell Line induced a physical association between Kit and Lck that, in vitro, was dependent on phosphorylation of the juxtamembrane domain of Kit. Stimulation of Kit with recombinant SCF resulted in a rapid 3-6-fold increase in the specific activity of Lck, which was similar in magnitude to the activation of Lck resulting from the cross-linking of the T-cell receptor complex of Jurkat cells. Lck activity peaked by 5 min after SCF addition, and the elevated activity persisted for at least 30 min in the presence of SCF, with kinetics similar to the activation of mitogen-activated protein kinase, PP1 an inhibitor of Src family kinases with selectivity for Lck, completely inhibited SCP-mediated growth but had little effect on insulin-like growth factor-I-mediated growth, PP1 antagonized both SCF-mediated proliferation and inhibition of apoptosis, PP1 had no effect on Kit kinase activity but was shown to block total Lck activity by at least 90% by immune complex kinase assay, Low levels of Src, Hck, and Yes mere also expressed in the H526 cell line; only Yes showed a consistent increase in specific activity, which was also inhibited by PP1 following SCF treatment. These data demonstrate that, in the H526 SCLC cell line, Lck and, possibly, Yes are downstream of Kit in a signal transduction pathway; the inhibition by PP1 of SCF-mediated proliferation and inhibition of apoptosis suggests that Src family kinases are intermediates in the signaling pathways that regulate these processes. [References: 33]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel